Sorriso Pharmaceuticals
San Diego
About Sorriso Pharmaceuticals
Sorriso Pharmaceuticals is a biotechnology company advancing a pipeline of disease-modifying antibodies for the treatment of inflammatory disease, including Crohn’s disease and ulcerative colitis. The Sorriso platform generates potent antibodies that can be delivered orally and are designed to maintain activity throughout the intestinal system. The company was founded in 2020 and is based in San Diego, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $31.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2021)
- Website: sorrisopharma.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/sorriso-pharmaceuticals-41277 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.